The present invention discloses compounds which, are novel antagonists for melanin-concentrating
hormone (MCH), as well as methods for preparing such compounds. In another embodiment,
the invention discloses pharmaceutical compositions comprising such MCH antagonists
as well as methods of using them to treat obesity, metabolic disorders, eating
disorders such as hyperphagia, and diabetes.
